SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is trending due to strong preliminary financial results and significantly raised growth outlook, driven by robust demand for its AI data center connectivity solutions from major hyperscalers. The community is actively discussing its valuation and the ongoing relevance of its copper-based technology amidst recent market volatility.

REGENXBIO, Inc. is a clinical-stage biotechnology company, which engages in the development, commercialization, and licensing of recombinant adeno-associated virus gene therapy. Its product candidates include the NAV Technology Platform, which consists of exclusive rights to novel adeno-associated viral vectors, and therapeutic programs such as RGX-314, RGX-202, RGX-121, RGX-111, RGX-181, and RGX-381. The company was founded by Kenneth T. Mills and James M. Wilson on July 16, 2008 and is headquartered in Rockville, MD.

Regenxbio Inc

Regenxbio is trending as the FDA issued a Complete Response Letter for its RGX-121 gene therapy for Hunter syndrome, citing trial design concerns and an ongoing clinical hold extended due to a potential adverse event in a related gene therapy utilizing the same AAV vector platform. The community is expressing significant disappointment over the rejection and its impact on RGNX's valuation, while also questioning the FDA's scrutiny of gene therapies and celebrating gains from short positions.

ImmunityBio, Inc. is a clinical stage immunotherapy company. It develops next generation therapies that drive immunogenic mechanisms for defeating cancers and infectious diseases. The company's immunotherapy platform activates both the innate and adaptive immune systems to create long term immunological memory. ImmunityBio was founded by Patrick Soon-Shiong in 2014 and is headquartered in San Diego, CA.

ImmunityBio Inc

ImmunityBio (IBRX) is rallying on community excitement around imminent EU approval for its cancer therapeutic, Anktiva, and intensified discussions of an 'Immunotherapy 2.0' partnership with Saudi Arabia for broad cancer indications. Investors are anticipating a significant short squeeze, validating the company's undervalued platform against recent industry acquisitions and its mission to deliver 'unstoppable' cancer treatments.

ON Semiconductor Corp. engages in the provision of intelligent power and sensing solutions with a primary focus on automotive and industrial markets. It operates through the following segments: Power Solutions Group (PSG), Analog and Mixed-Signal Group (AMG), and Intelligent Sensing Group (ISG). The PSG segment offers discrete, module, and integrated semiconductor products that perform multiple application functions, including power switching, signal conditioning, and circuit protection. The AMG segment designs and develops analog, mixed-signal, power management integrated circuits, sensor interface devices, power conversion, signal chain, and voltage regulation devices. The ISG focuses on the design and development of complementary metal oxide semiconductor image sensors, image signal processors, single photon detectors, including silicon photomultipliers, single photon avalanche diode arrays, and short-wavelength infrared products, as well as actuator drivers for autofocus and image stabilization. The company was founded on July 4, 1999 and is headquartered in Scottsdale, AZ.

ON Semiconductor Corp.

ON Semiconductor is trending as recent weak guidance for the coming quarter has driven a sell-off and ignited community debate over decelerating automotive and industrial demand. While bears foresee further drops, bulls are underscoring the company's strategic pivot to AI data centers with a significant Nvidia partnership and a large share repurchase program.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is trending following its earnings report, sparking community discussion over a notable stock decline despite positive EPS growth and reaffirmed guidance, with many attributing the dip to revenue shifts while maintaining strong long-term confidence in its extensive backlog of critical government, defense, and nuclear contracts.

Upwork, Inc. is an online marketplace which engages in the provision of businesses to find, hire, and pay freelancers for short-term and longer-term projects. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Business, Upwork Enterprise, and Upwork Payroll. The company was founded by Odysseas Tsatalos and Efstratios Karamanlakis in December 2013 and is headquartered in Palo Alto, CA.

Upwork Inc

Upwork is trending following its strong earnings beat, raised guidance, and a new share repurchase program, which are driving renewed bullish sentiment and analyst upgrades. Community discussion centers on its perceived undervaluation and potential for a short squeeze, as the company emphasizes strategic AI innovations within the evolving gig economy.

Astera Labs, Inc. is a global semiconductor company, which engages in the provision of hardware and software solutions for AI and cloud infrastructure applications to solve data, memory, and networking bottlenecks. It operates through the following geographical segments: Taiwan, China, United States, and Other. The company was founded by Jitendra Mohan, Casey Morrison, and Sanjay Gajendra in October 2017 and headquartered in San Jose, CA.

Astera Labs Inc.

Astera Labs Inc

Astera Labs is a top trending stock, buoyed by recent analyst upgrades and its pivotal role in the rapidly expanding AI data center infrastructure. The community is highly focused on its essential high-speed connectivity solutions, strategic optical technology acquisitions, and potential for significant growth driven by hyperscaler spending.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

With its upcoming earnings report sparking significant options activity, Fiserv (FISV) is trending amidst a polarized community debate: optimists highlight recent insider and institutional buying alongside deep undervaluation, while skeptics worry about the stock's persistent weakness and broader fintech sector headwinds exacerbated by AI disruption concerns.

Kyndryl Holdings, Inc. is a technology services company, which engages in the provision of infrastructure services. It operates through the following segments: United States, Japan, Principal Markets, and Strategic Markets. The Principal Markets segment represents the aggregation of operations in Australia, New Zealand, Canada, France, Germany, India, Italy, Spain, Portugal, the United Kingdom, and Ireland. The company was founded on December 4, 2020 and is headquartered in New York, NY.

Kyndryl Holdings Inc

Kyndryl Holdings is trending sharply lower following the abrupt departures of its CFO and General Counsel amid an accounting review and delayed financial filings, sparking intense community discussion about whether the significant sell-off is an extreme overreaction or indicative of severe internal control issues.

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases. Its mission is to develop disease-modifying therapeutics that aim to resolve fibrosis and restore organ function, enabling patients with these disorders to live fuller and healthier lives. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium.

AgomAb Therapeutics NV - ADR

AGMB is experiencing heightened attention as a new IPO amid extreme volatility, with community discussions largely focused on its low float potentially fueling a short squeeze.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

<ul class="summary-bullets"><li>On Dec. 31, 2025, INBS stock closed over 132% after announcing a manufacturing partnership with Syrma Johari MedTech.</li><li>The company also announced a private placement with two healthcare-focused institutional investors to issue 2.3 million shares of common stock.</li><li>Intelligent Bio Solutions had announced a 1-for-10 reverse stock split effective Dec. 15.</li></ul>Shares of Intelligent Bio Solutions (INBS) have seen strong buying interest in recent weeks, with the stock adding more than 35% in premarket trading on Monday.&nbsp;From the close on Dec. 30, 2025, to Jan. 9, 2026, <a href="https://stocktwits.com/symbol/INBS">INBS stock</a> has surged about 337%, breaching both its 50-day moving average (50-DMA) and the longer-term 200-DMA during the rally.This stellar rally has made it a momentum favorite among retail traders, driven by a recent manufacturing partnership, fresh capital boost, and a compliance update with Nasdaq; however, concerns around dilution and its volatile ride continue to temper sentiment.&nbsp;<h2 class="st-heading-2">What Led To INBS Rally?</h2>On Dec. 31, 2025, INBS stock closed over 132% after announcing a manufacturing partnership with Syrma Johari MedTech to scale production of its fingerprint drug-screening reader. The deal is expected to cut annual production costs by over 40% and lift gross margins by about 20 percentage points, while expanding manufacturing capacity fourfold, Intelligent Bio Solutions said. The company said the deal positions it well for its U.S. market launch in 2026.The company also announced a private placement with two healthcare-focused institutional investors to issue 2.3 million shares of common stock along with Series K-1 and K-2 warrants for the same number of shares at $4.35 each, raising around $10 million before fees. The warrants have an exercise price of $4.10 per share.Separately, on January 7, Intelligent Bio Solutions was notified by Nasdaq that it had regained compliance to trade on the Nasdaq Capital Market. The closing bid price of INBS stock had remained at $1.00 or higher for 14 consecutive business days, from Dec. 16, 2025, to Jan. 6, 2026. The company had announced a 1-for-10 reverse stock split effective Dec. 15.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Despite the bullish premarket movement, retail sentiment on Stocktwits remained in the ‘neutral’ zone over the past 24 hours. INBS was among the top-trending tickers on Stocktwits at the time of writing.One user thinks short interest is extremely high and predicts the stock could fall to $15. It is currently trading at $24.2.<stembedurl>https://stocktwits.com/Harsh1210/message/641505295</stembedurl>However, another user sees a setup that pits the company’s operational progress against short-term dilution fears.<stembedurl>https://stocktwits.com/Atdanaiw/message/641502687</stembedurl>Read also: <a href="https://stocktwits.com/news-articles/markets/equity/silver-gold-record-highs-analyst-michael-oliver-predicts-500-breakout/cmU9UNvR4Ec">Silver’s Next Move Could Be Explosive: Michael Oliver Sees $200–$500 Upside</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

INBS Stock Has Surged Over 330% So Far In January – But Retail Traders Are Warning Of A Pullback 

INBS shares were up more than 35% in premarket trading on Monday and were among the top trending tickers on Stocktwits.

INBS Stock Gains Triple-Digit Rally So Far In January: What’s Driving The Surge And What Traders Are Saying

Equity

Why Intelligent Bio Solutions Shares Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session

INBS Stock Surges 132.4% on New Manufacturing Partnership 

Intelligent Bio Solutions' stock jumps after a new manufacturing partnership aimed at cutting costs, boosting margins and scaling production ahead of U.S. expansion.

Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session

Stock Market Today: S&P 500, Dow Futures Gain On The First Trading Day Of 2026 Baidu, Rubico, Intelligent Bio Solutions In Focus

U.S. stock futures rose on the first trading day of the year on Friday after missing the Santa Claus rally over the truncated week. Futures of major benchmark indices were higher. The Santa Claus...

<ul class="summary-bullets"><li>Retail sentiment improved for SPY and QQQ on Stocktwits.</li><li>Traders are eyeing Tesla’s delivery data and a surge in silver prices.</li><li>Baidu drew retail attention after its chip unit filed for an IPO.</li></ul>U.S. stock futures were trading higher early Friday as markets reopened for the first full trading session of 2026. Wall Street is looking to break a three-year streak of opening-day losses. The S&amp;P 500 has had a negative close on its first trading day&nbsp;in each of the last three years (2023-2025).As of 2:50 a.m. ET on Friday, Nasdaq 100 futures were up 0.7%, S&amp;P 500 futures rose 0.4%, and the Dow futures gained 0.1%, while Russell 2000 futures rose 0.4%.On Stocktwits, the retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, moved to ‘bullish’ from ‘neutral’ a day ago. And sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq 100 Index, has remained ‘bullish’, amid low message volumes.&nbsp;<h2 class="st-heading-2">Trending Stocks To Watch</h2> Baidu (BIDU): Trending following news that its chip unit filed for an IPO, sparking a renewed interest in ‘China AI’ discount plays. Tesla (TSLA): High search volume and social chatter ahead of its Q4 delivery report expected today. Meanwhile, reports suggest that China’s BYD has officially dethroned it as the global EV king for the full year 2025. NIO is trending high on Stocktwits as well.&nbsp; Watch out for&nbsp;iShares Silver Trust (SLV):&nbsp;Silver jumped 2.5% in early trading, building on its best annual performance since 1979.Stellantis (STLA): The company is resurrecting a gas-powered Ram pickup truck, the TRX, with a V-8 engine, as it faces fewer federal emissions regulations, CNBC reported.Other noteworthy tickers trending on Stocktwits at the time of writing were Intelligent Bio Solutions (INBS), BigBear.ai (BBAI), Corcept Therapeutics (CORT), and Sensei BioTherapeutics (SNSE).&nbsp;<h2 class="st-heading-2">Other Catalysts To Watch</h2>On the economic front, investors are looking ahead to the release of the Fed Balance Sheet (4:30 PM ET). Markets will be eyeing updates on ‘Quantitative Tightening’ (QT) pacing. For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Point To Strong New-Year Open On Wall Street: Why TSLA, BIDU, SLV, STLA Are On Traders' Radar Today

Wall Street is hoping to break a three-year streak of opening-day losses.

Top Medical Stocks To Consider - January 1st

Eli Lilly and Company, UnitedHealth Group, Intelligent Bio Solutions, Johnson & Johnson, Merck & Co., Inc., Pfizer, and Corcept Therapeutics are the seven Medical stocks to watch today, according to...

Intelligent Bio Solutions Stock Surges 188% On New Manufacturing Partnership

(RTTNews) - Intelligent Bio Solutions Inc. (INBS) shares jumped 187.68%, trading at $11.80, up $7.70, after the company announced a new manufacturing partnership aimed at strengthening global...

Best Value Stocks To Consider - December 31st

Invesco QQQ, Ondas, Intelligent Bio Solutions, ProShares UltraPro Short QQQ, Rocket Lab, CoreWeave, and D-Wave Quantum are the seven Value stocks to watch today, according to MarketBeat's stock...

Intelligent Bio Stock Doubles On New Manufacturing Deal Promising Major Cost Cuts

Intelligent Bio Solutions stock rises after announcing a manufacturing partnership targeting over 40% cost savings, major margin improvement, and expanded global production capacity ahead of planned...

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Beat EPS and revenue

Beat EPS, miss revenue

Miss EPS, beat revenue

Miss EPS and revenue

What do you expect from $HOOD earnings on Tuesday?

INBS
Intelligent Bio Solutions Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest INBS News

INBSIntelligent Bio Solutions Inc